{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:41:30Z","timestamp":1789670490630,"version":"4.0.1"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Antimicrobial resistance (AMR) data in the pediatric population are limited, particularly in developing countries. This study assessed the AMR profile and key resistance phenotypes and genotypes for Gram-negative bacteria (GNB) isolates collected as part of the Antimicrobial Testing Leadership and Surveillance program from pediatric patients in Latin America, Africa-Middle East, and Asia in 2016\u20132020 versus 2011\u20132015.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Minimum inhibitory concentrations by broth microdilution methodology were interpreted per the Clinical and Laboratory Standards Institute. European Committee on Antimicrobial Susceptibility Testing breakpoints were used for interpreting colistin activity. \u03b2-lactamase genes were screened by polymerase chain reaction and sequencing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>For Acinetobacter baumannii, low susceptibility (&amp;lt;60.0%) was observed for all antimicrobials, except colistin (\u226592.9%), across regions and year periods. Ceftazidime-avibactam, amikacin, colistin, and meropenem were mostly active (78.6%\u2013100.0%) against Enterobacter cloacae, Escherichia coli, and Klebsiella pneumoniae. For Pseudomonas aeruginosa, susceptibility to ceftazidime-avibactam, amikacin, and colistin was \u226585.9%. Among resistance phenotypes, carbapenem-resistant (CR, \u226544.8%) and difficult-to-treat resistant (DTR, \u226537.1%) rates were the highest in A. baumannii. A consistent increase in CR and DTR K. pneumoniae was noted across regions over time. Extended-spectrum \u03b2-lactamases (ESBL)-producing K. pneumoniae (32.6%\u201355.6%) were more frequent than ESBL-producing E. coli (25.3%\u201337.1%). CTX-M was the dominant ESBL among Enterobacterales. NDM-positive Enterobacterales species and VIM-positive P. aeruginosa were identified across regions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study identified high susceptibility to few agents for key GNB in pediatric patients. Continued surveillance of resistance phenotypes and genotypes at regional levels may help to guide appropriate treatment decisions.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jpids\/piad055","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T13:37:06Z","timestamp":1691674626000},"page":"459-470","source":"Crossref","is-referenced-by-count":12,"title":["Antimicrobial Susceptibility Among Gram-Negative Isolates in Pediatric Patients in Latin America, Africa-Middle East, and Asia From 2016\u20132020 Compared to 2011\u20132015: Results From the ATLAS Surveillance Study"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0585-9255","authenticated-orcid":false,"given":"Qiwen","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Kamat","sequence":"additional","affiliation":[{"name":"Pfizer Ltd. , Mumbai , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Pfizer Inc. , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Ricardo","family":"Valdez","sequence":"additional","affiliation":[{"name":"Pfizer Latin America , Mexico , Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Lin","sequence":"additional","affiliation":[{"name":"Pfizer Emerging Asia Region , Taipei , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Su","sequence":"additional","affiliation":[{"name":"Pfizer Ltd. , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Quintana","sequence":"additional","affiliation":[{"name":"Pfizer Inc. , New York, New York , USA (retired)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattarachai","family":"Kiratisin","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University , Bangkok , Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Patricia","family":"Rodr\u00edguez-Zulueta","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Hospital General Dr. Manuel GEA Gonz\u00e1lez , Mexico City , Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Brink","sequence":"additional","affiliation":[{"name":"Division of Medical Microbiology, Faculty of Health Sciences, University of Cape Town , Cape Town , South Africa"},{"name":"National Health Laboratory Service, Groote Schuur Hospital, University of Cape Town , Cape Town , South Africa"},{"name":"Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town , Cape Town , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"key":"2024011912094889400_CIT0001","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/QCO.0000000000000371","article-title":"Antimicrobial-resistant Gram-negative infections in neonates: burden of disease and challenges in treatment","volume":"30","author":"Folgori","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"2024011912094889400_CIT0002","doi-asserted-by":"crossref","first-page":"205031212210941","DOI":"10.1177\/20503121221094191","article-title":"Gram-negative bacteria isolates and their antibiotic-resistance patterns among pediatrics patients in Ethiopia: a systematic review","volume":"10","author":"Kebede","year":"2022","journal-title":"SAGE Open Med"},{"key":"2024011912094889400_CIT0003","doi-asserted-by":"crossref","first-page":"115108","DOI":"10.1016\/j.diagmicrobio.2020.115108","article-title":"Frequency and antimicrobial susceptibility of bacteria causing bloodstream infections in pediatric patients from United States (US) medical centers (2014-2018): therapeutic options for multidrug-resistant bacteria","volume":"98","author":"Sader","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2024011912094889400_CIT0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jacamr\/dlaa066","article-title":"Healthcare-associated bacterial infections in the paediatric ICU","volume":"2","author":"Akinkugbe","year":"2020","journal-title":"JAC Antimicrob Resist"},{"key":"2024011912094889400_CIT0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000503746","article-title":"Emergence of carbapenem-hydrolyzing oxacillinases in Acinetobacter baumannii in children from Croatia","volume":"64","author":"Luki\u0107-Grli\u0107","year":"2019","journal-title":"Chemotherapy"},{"key":"2024011912094889400_CIT0006","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/jpids\/piy018","article-title":"Acinetobacter baumannii resistance trends in children in the United States, 1999-2012","volume":"8","author":"Logan","year":"2019","journal-title":"J Pediatr Infect Dis Soc"},{"key":"2024011912094889400_CIT0007","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/INF.0000000000002176","article-title":"A multi-centered case-case-control study of factors associated with Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae infections in children and young adults","volume":"38","author":"Logan","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"2024011912094889400_CIT0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-017-0208-x","article-title":"The threat of antimicrobial resistance in developing countries: causes and control strategies","volume":"6","author":"Ayukekbong","year":"2017","journal-title":"Antimicrob Resist Infect Control"},{"key":"2024011912094889400_CIT0009","doi-asserted-by":"crossref","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","article-title":"Global increase and geographic convergence in antibiotic consumption between 2000 and 2015","volume":"115","author":"Klein","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024011912094889400_CIT0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1473-3099(19)30572-9","article-title":"Antibiotic exposure among children younger than 5 years in low-income and middle-income countries: a cross-sectional study of nationally representative facility-based and household-based surveys","volume":"20","author":"Fink","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2024011912094889400_CIT0011","doi-asserted-by":"crossref","first-page":"e893","DOI":"10.1016\/S2542-5196(21)00280-1","article-title":"Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study","volume":"5","author":"Browne","year":"2021","journal-title":"Lancet Planet Health"},{"key":"2024011912094889400_CIT0012","doi-asserted-by":"crossref","first-page":"e799","DOI":"10.1016\/S2214-109X(20)30079-6","article-title":"Trends in reported antibiotic use among children under 5 years of age with fever, diarrhoea, or cough with fast or difficult breathing across low-income and middle-income countries in 2005-17: a systematic analysis of 132 national surveys from 73 countries","volume":"8","author":"Allwell-Brown","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2024011912094889400_CIT0013","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40545-022-00454-8","article-title":"Non-prescribed antibiotic use for children at community levels in low- and middle-income countries: a systematic review and meta-analysis","volume":"15","author":"Edessa","year":"2022","journal-title":"J Pharm Policy Pract"},{"key":"2024011912094889400_CIT0014","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1016\/S2214-109X(21)00024-3","article-title":"Community-based antibiotic access and use in six low-income and middle-income countries: a mixed-method approach","volume":"9","author":"Do","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2024011912094889400_CIT0015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","journal-title":"Lancet"},{"key":"2024011912094889400_CIT0016","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000362085","article-title":"Antibiotic resistance of Gram-negative bacilli isolated from pediatric patients with nosocomial bloodstream infections in a Mexican tertiary care hospital","volume":"59","author":"Ares","year":"2013","journal-title":"Chemotherapy"},{"key":"2024011912094889400_CIT0017","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3947\/ic.2016.48.3.181","article-title":"Increase in antibiotic-resistant Gram-negative bacterial infections in febrile neutropenic children","volume":"48","author":"Lee","year":"2016","journal-title":"Infect Chemother"},{"key":"2024011912094889400_CIT0018","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/mdr.2017.0031","article-title":"Epidemiology of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in a Chinese children\u2019s hospital: predominance of New Delhi metallo-\u03b2-lactamase-1","volume":"24","author":"Dong","year":"2018","journal-title":"Microb Drug Resist"},{"key":"2024011912094889400_CIT0019","first-page":"39","article-title":"Pattern of bacterial profile and antibiotic susceptibility among neonatal sepsis cases at Cairo University Children Hospital","volume":"15","author":"Almohammady","year":"2020","journal-title":"J Taibah Univ Med Sci"},{"key":"2024011912094889400_CIT0020","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2024011912094889400_CIT0021","first-page":"1803","article-title":"Difficult-to-treat resistance in Gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents","volume":"67","author":"Kadri","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2024011912094889400_CIT0022","author":"ATLAS Surveillance"},{"key":"2024011912094889400_CIT0023","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standards","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2018","edition":"11"},{"key":"2024011912094889400_CIT0024","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2022","edition":"32"},{"key":"2024011912094889400_CIT0025","author":"European Committee on Antimicrobial Susceptibility Testing"},{"key":"2024011912094889400_CIT0026","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1128\/AAC.00220-16","article-title":"In vitro susceptibility of global surveillance isolates of Pseudomonas aeruginosa to ceftazidime-avibactam (INFORM 2012 to 2014)","volume":"60","author":"Nichols","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2024011912094889400_CIT0027","doi-asserted-by":"crossref","first-page":"dlac060","DOI":"10.1093\/jacamr\/dlac060","article-title":"Carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa causing infection in Africa and the Middle East: a surveillance study from the ATLAS programme (2018-20)","volume":"4","author":"Karlowsky","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"2024011912094889400_CIT0028","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1128\/JCM.03184-14","article-title":"Global assessment of antimicrobial susceptibility among Gram-negative organisms collected from pediatric patients between 2004 and 2012: results from the Tigecycline Evaluation and Surveillance Trial","volume":"53","author":"Kehl","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2024011912094889400_CIT0029","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.2147\/IDR.S223736","article-title":"Antimicrobial resistance and resistance determinant insights into multi-drug resistant Gram-negative bacteria isolates from paediatric patients in China","volume":"12","author":"Patil","year":"2019","journal-title":"Infect Drug Resist"},{"key":"2024011912094889400_CIT0030","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","article-title":"Infectious Diseases Society of America Guidance on the treatment of AmpC \u03b2-lactamase-producing enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections","volume":"74","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2024011912094889400_CIT0031","doi-asserted-by":"crossref","first-page":"e0028321","DOI":"10.1128\/Spectrum.00283-21","article-title":"Bacterial epidemiology and antimicrobial resistance profiles in children reported by the ISPED program in China, 2016 to 2020","volume":"9","author":"Fu","year":"2021","journal-title":"Microbiol Spectr"},{"key":"2024011912094889400_CIT0032","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ijantimicag.2019.01.015","article-title":"Activity of ceftolozane-tazobactam and comparators when tested against Gram-negative isolates collected from paediatric patients in the USA and Europe between 2012 and 2016 as part of a global surveillance programme","volume":"53","author":"Shortridge","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"2024011912094889400_CIT0033","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.3346\/jkms.2022.37.e196","article-title":"The changes in epidemiology of imipenem-resistant Acinetobacter baumannii bacteremia in a pediatric intensive care unit for 17 years","volume":"37","author":"Kim","year":"2022","journal-title":"J Korean Med Sci"},{"key":"2024011912094889400_CIT0034","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.2147\/IDR.S365139","article-title":"Trends in DTR, CR, ECR, and FQR in four common Gram-negative bacteria: a retrospective study from 2013 to 2021","volume":"15","author":"Zhang","year":"2022","journal-title":"Infect Drug Resist"},{"key":"2024011912094889400_CIT0035","doi-asserted-by":"crossref","first-page":"863129","DOI":"10.3389\/fmicb.2022.863129","article-title":"Molecular characterisation of Acinetobacter baumannii isolates from bloodstream infections in a tertiary-level hospital in South Africa","volume":"13","author":"Lowe","year":"2022","journal-title":"Front Microbiol"},{"key":"2024011912094889400_CIT0036","doi-asserted-by":"crossref","first-page":"e0271355","DOI":"10.1371\/journal.pone.0271355","article-title":"Acinetobacter baumannii complex, national laboratory-based surveillance in South Africa, 2017 to 2019","volume":"17","author":"Perovic","year":"2022","journal-title":"PLoS One"},{"key":"2024011912094889400_CIT0037","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pedneo.2017.06.001","article-title":"Clinical characteristics and epidemiology of sepsis in the neonatal intensive care unit in the era of multi-drug resistant organisms: a retrospective review","volume":"59","author":"Yusef","year":"2018","journal-title":"Pediatr Neonatol"},{"key":"2024011912094889400_CIT0038","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s40121-023-00799-w","article-title":"A narrative review of healthcare-associated Gram-negative infections among pediatric patients in middle eastern countries","volume":"12","author":"Al Dabbagh","year":"2023","journal-title":"Infect Dis Ther"},{"key":"2024011912094889400_CIT0039","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4103\/sjmms.sjmms_855_20","article-title":"Antibiotic resistance pattern of Acinetobacter baumannii strains: a retrospective study from Oman","volume":"9","author":"Sannathimmappa","year":"2021","journal-title":"Saudi J Med Med Sci"},{"key":"2024011912094889400_CIT0040","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1093\/cid\/ciy657","article-title":"Current status and trends of antibacterial resistance in China","volume":"67","author":"Hu","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2024011912094889400_CIT0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-016-1805-7","article-title":"Molecular epidemiology of carbapenem resistant Gram-negative bacilli from infected pediatric population in tertiary-care hospitals in Medell\u00edn, Colombia: an increasing problem","volume":"16","author":"Vanegas","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2024011912094889400_CIT0042","doi-asserted-by":"crossref","first-page":"e0241776","DOI":"10.1371\/journal.pone.0241776","article-title":"Colonisation with extended spectrum beta-lactamase-producing and carbapenem-resistant Enterobacterales in children admitted to a paediatric referral hospital in South Africa","volume":"15","author":"Ogunbosi","year":"2020","journal-title":"PLoS One"},{"key":"2024011912094889400_CIT0043","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2147\/IDR.S357090","article-title":"Community fecal carriage and molecular epidemiology of extended-spectrum \u03b2-lactamase- and carbapenemase-producing Escherichia coli from healthy children in the Central South China","volume":"15","author":"Liu","year":"2022","journal-title":"Infect Drug Resist"},{"key":"2024011912094889400_CIT0044","doi-asserted-by":"crossref","first-page":"e0200021","DOI":"10.1128\/AAC.02000-21","article-title":"Geographic patterns of carbapenem-resistant Pseudomonas aeruginosa in the Asia-Pacific region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2015-2019","volume":"66","author":"Lee","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2024011912094889400_CIT0045","doi-asserted-by":"crossref","first-page":"e0112221","DOI":"10.1128\/Spectrum.01122-21","article-title":"Fecal carriage and molecular characterization of carbapenemase-producing enterobacterales in the pediatric population in Qatar","volume":"9","author":"P\u00e9rez-L\u00f3pez","year":"2021","journal-title":"Microbiol Spectr"},{"key":"2024011912094889400_CIT0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2020.00314","article-title":"Dissemination of carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) among carbapenem-resistant enterobacteriaceae isolated from adult and children patients in China","volume":"10","author":"Han","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"2024011912094889400_CIT0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2020.581711","article-title":"Molecular characterization of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae among the pediatric population in Qatar","volume":"11","author":"Perez-Lopez","year":"2020","journal-title":"Front Microbiol"},{"key":"2024011912094889400_CIT0048","doi-asserted-by":"crossref","first-page":"117863361773901","DOI":"10.1177\/1178633617739018","article-title":"Molecular epidemiology of extended-spectrum \u03b2-lactamase-producing Escherichia coli pathotypes in diarrheal children from low socioeconomic status communities in Bihar, India: emergence of the CTX-M type","volume":"10","author":"Mandal","year":"2017","journal-title":"Infect Dis (Auckl)"},{"key":"2024011912094889400_CIT0049","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jgar.2020.09.010","article-title":"Emergence and spread of VIM-type metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa clinical isolates in Japan","volume":"23","author":"Hishinuma","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"2024011912094889400_CIT0050","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3855\/jidc.10679","article-title":"Occurrence of VIM-4 metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa in an Algerian hospital","volume":"13","author":"Merradi","year":"2019","journal-title":"J Infect Dev Ctries"},{"key":"2024011912094889400_CIT0051","doi-asserted-by":"crossref","first-page":"e00592","DOI":"10.1128\/AAC.00592-18","article-title":"In vitro activity of ceftazidime-avibactam and aztreonam-avibactam against OXA-48-carrying enterobacteriaceae isolated as part of the International Network for Optimal Resistance Monitoring (INFORM) global surveillance program from 2012 to 2015","volume":"62","author":"Kazmierczak","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2024011912094889400_CIT0052","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13756-022-01085-z","article-title":"Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021)","volume":"11","author":"Kariyawasam","year":"2022","journal-title":"Antimicrob Resist Infect Control"},{"key":"2024011912094889400_CIT0053","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/iub.2356","article-title":"Bacterial co-infections with SARS-CoV-2","volume":"72","author":"Mirzaei","year":"2020","journal-title":"IUBMB Life"},{"key":"2024011912094889400_CIT0054","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024011912094889400_CIT0055","doi-asserted-by":"crossref","first-page":"14757","DOI":"10.1038\/s41598-021-94295-1","article-title":"Epidemiology, risk factors, and prediction score of carbapenem resistance among inpatients colonized or infected with 3rd generation cephalosporin resistant Enterobacterales","volume":"11","author":"Moghnieh","year":"2021","journal-title":"Sci Rep"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpids\/advance-article-pdf\/doi\/10.1093\/jpids\/piad055\/51081421\/piad055.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/12\/8\/459\/56248266\/piad055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/12\/8\/459\/56248266\/piad055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T12:10:54Z","timestamp":1705666254000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/12\/8\/459\/7240364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":55,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8,10]]},"published-print":{"date-parts":[[2023,8,31]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piad055","relation":{},"ISSN":["2048-7207"],"issn-type":[{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8,1]]},"published":{"date-parts":[[2023,8,1]]}}}